Close Menu

NEW YORK – For many diagnostic firms, developing a portable immunoanalyzer has meant sacrificing sensitivity and specificity. Startup Proxim Diagnostics believes its Profile platform has solved the puzzle and is working to get its cartridge-based, handheld instrument ready for use during the SARS-CoV-2 pandemic.

The fully automated instrument performs enzyme-linked immunosorbent assays, much in the same way as larger immunoanalzyers used in central labs, such as Roche's Cobas or Abbott's Architect systems, said Proxim CEO Mikhail Briman. 

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.